MedPath

A randomized controlled trial comparing the efficacy of pregabalin versus lignocaine for attenuating the intubation response in hypertensive patients.

Not Applicable
Not yet recruiting
Conditions
Hypertension
Registration Number
SLCTR/2018/032
Lead Sponsor
Vinayaka Missions Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1. Males and females under the age limit of 60 years
2. Undergoing elective surgery requiring general anaesthesia
3. Hypertensive patients on antihypertensive medications with BP (blood pressure) less than or equal to 160/90 mmHg

Exclusion Criteria

1. Uncontrolled hypertension defined as blood pressure above 160/90 mmHg
2. Significant cardiorespiratory illness such as IHD, left heart failure, severe COPD and cor pulmonale
3. Psychiatric medication including sedative intake (Tricyclic antidepressants, Selective serotonin reuptake inhibitors, Serotonin and norepinephrine reuptake inhibitors)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.